Tom McFarlane

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsChemotherapyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2025
Development of Ambulatory Oncology Clinical Pharmacy Key Performance Indicators Using a Modified Delphi Consensus Approach.

Thomas McFarlane, Rozhannaa Sothilingam, Olavo Fernandes

|Jul 25, 2025
Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers.

Angela Chan, Nancy Nixon, Muna Al-Khaifi

|May 09, 2024
Review of drug-drug interactions in patients with prostate cancer.

Andrew Ruplin, Eve Segal, Tom McFarlane

|Mar 15, 2024
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis.

Lisa Masucci, Feng Tian, Stephen Tully

|Aug 25, 2023
Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective.

Jan-Willem Henning, Jean-François Boileau, Larissa Peck

|Dec 20, 2022
Exploration of current pharmacy practice in cardio-oncology: Experiences & perspectives.

Alisha Merali, Maria Anwar, Jamie M Boyd

Pageof 2